Shanghai Forxine Pharmaceutical.Co.,Ltd.

Founded in 2014, Shanghai Forxine Pharmaceutical.Co.,Ltd. (forxine.com) is a manufacturer specializing in boron chemistry for pharmaceutical synthesis. Its product line includes CBS-oxazaborolidine chiral reduction catalysts, borane complexes (dimethyl sulfide, pyridine, tetrahydrofuran and N,N-diethylaniline complexes), chlorodiisopinocampheylborane and diisopinocampheyl chloroborane reagents, boronic acids and pinacol boronate esters, and other boron-containing building blocks and coupling reagents used as chiral building blocks in drug synthesis. The company offers CDMO contract services under its own brand, and positions itself on internationally recognized approvals, experienced R&D staff, favorable delivery terms, production capacity and service reputation, selling to North and South America, Western and Eastern Europe, Australasia, Asia, the Middle East and Africa.